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Genetic investigation of inherited skin disorders has informed the understanding of skin self-renewal,
differentiation, and barrier function. Erythrokeratodermia variabilis et progressiva (EKVP) is a rare, inherited skin
disease that is characterized by transient figurate patches of erythema, localized or generalized scaling, and
frequent palmoplantar keratoderma. By using exome sequencing, we show that de novo missense mutations in
GJA1 (gap junction protein alpha 1) cause EKVP. The severe, progressive skin disease in EKVP subjects with GJA1
mutations is distinct from limited cutaneous findings rarely found in the systemic disorder oculodentodigital
dysplasia, also caused by dominant GJA1mutations. GJA1 encodes connexin 43 (Cx43), the most widely expressed
gap junction protein. We show that the GJA1 mutations in EKVP subjects lead to disruption of Cx43 membrane
localization and aggregation within the Golgi. These findings reveal a critical role for Cx43 in epidermal
homeostasis, and they provide evidence of organ-specific pathobiology resulting from different mutations within
GJA1.
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INTRODUCTION
Erythrokeratodermia variabilis (MIM 133200) is a rare, congeni-
tal skin disorder characterized by transient figurate patches of
erythema on a background of localized or generalized scaling,
with palmoplantar keratoderma present in nearly 50% of cases
(Richard, 2000). Erythrokeratodermia variabilis is primarily
inherited in an autosomal dominant manner, although rare
autosomal recessive inheritance has been reported (Gottfried
et al., 2002; Fuchs-Telem et al., 2011), and it shows marked
phenotypic heterogeneity, even within kindreds bearing the
same disease-causing mutation (van Steensel et al., 2009). The
term erythrokeratodermia variabilis et progressiva (EKVP) has
been proposed to encompass the diversity of phenotypes,
ranging from limited hyperkeratotic plaques and erythematous
patches to severe progressive symmetric erythrokeratodermia,
which can feature more generalized cutaneous involvement
(van Steensel, 2004). Mutations in GJB3 and GJB4, encoding
connexins 31 and 30.3, respectively, have been reported to
cause erythrokeratodermia variabilis/EKVP (Richard et al., 1998;
Macari et al., 2000), although there is evidence of further genetic
heterogeneity (Common et al., 2005; Wei et al., 2011).
Connexin proteins are named for their molecular weight in
kDa (Pfenniger et al., 2011), and they are phylogenetically
classified into alpha and beta subgroups (Martin et al., 2014),
encoded by GJA and GJB genes. All connexin proteins have a
conserved structure and topology, consisting of a cytoplasmic
N terminus and C terminus, and four transmembrane domains
connected by two extracellular loops and one cytoplasmic
loop. After translation, connexins oligomerize to form hexameric
connexons in the endoplasmic reticulum and Golgi, and they
are transported to the membrane where they can either
function as nonjunctional hemichannels between the
cytoplasm and extracellular space or dock with partners in
neighboring cells to form intercellular gap junctions. These
channels provide both critical communication pathways,
allowing passage of ions and small molecules, and structural
support to tissues, accumulating to create large plaques.
A diversity of potential permeabilities are possible via homo-
meric or heteromeric connexon configuration, and homotypic
or heterotypic interactions between cells (Mes¸e et al., 2007).
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Gap junctions have diverse and important roles in normal
physiology, and mutations in connexin genes cause a variety
of pathological phenotypes including cardiovascular disease,
myelin-related disease, skin disease, craniofacial disorders,
and hearing loss (Pfenniger et al., 2011; Scott et al., 2012).
In recruiting subjects with EKVP-spectrum phenotypes, we
identified a cohort without mutation in GJB3 or GJB4,
including kindreds 101–103. Each kindred consists of one
affected subject born to unaffected parents.
RESULTS
Subject 101-1 is a 32-month-old boy who had no clinical
phenotype until the age of 5 months. He then developed thick
brown-gray scale on frictional surfaces (Figure 1a), as well as
progressive darkening of his dorsal hands, arms, legs, and
face. His palmoplantar surfaces and digits became pink and
then markedly hyperkeratotic (Figure 2a), and migrating areas
of transient figurate erythema overlay the generalized scaling
(Figure 3a).
Subject 102-1 is a 6-year-old girl who was adopted from
Guatemala at 6 months of age without notable skin disease
(Supplementary Figure S1a online). At 8 months, she devel-
oped darkening and scaling of frictional surfaces (Figure 1b)
and the dorsal hands, and progressive thickening of the palms
and soles (Figure 2b). By the age of 13 months, hyperpig-
mented, hyperkeratotic plaques appeared, affecting the axil-
lae, elbows, and inner thighs; these became confluent by the
age of 2 years, with sparing of cheeks and upper chest
(Figure 3b). She has intermittent annular red patches that fade
within hours after onset.
Subject 103-1 is a 30-year-old woman who had normal skin
through 6 months of age (Supplementary Figure S1b online),
after which darkening of the inner thighs was noted, followed
by development of a thick scale, which began on the knees,
elbows, hands, and feet and then progressively spread up the
legs and arms (Figures 1c and 2c). At the age of 10 years, pink
to deep red transient erythematous patches, which were
associated with a burning sensation, became prominent
(Figure 3c). Oral acitretin therapy has reduced scale and
improved keratoderma.
All subjects exhibit enlarged porcelain-white lunulae
(Figure 2, Supplementary Figure S2 online) and darkening of
periorificial areas (Supplementary Figure S3 online). Histology
of the most severely affected skin in each case shows papillo-
matosis, acanthosis, hypergranulosis, and compact orthohy-
perkeratosis with retained nuclei (Figure 1d and Supplementary
Figure S4 online). In less severely affected skin, acanthosis,
papillomatosis, orthohyperkeratosis, and follicular plugging is
found (Supplementary Figure S4 online).
Exome sequencing was performed from peripheral blood
DNA of affected subjects (Supplementary Table S1 online).
Sequences were aligned to the reference human genome,
variants were annotated, and data were examined to identify
novel coding mutations. Analysis revealed the same hetero-
zygous missense mutation in gap junction protein alpha 1
(GJA1), E227D, in two affected subjects: 101-1 and 102-1.
Another heterozygous GJA1 mutation, A44V, was found in a
third affected subject: 103-1 (Supplementary Figure S5 online).
Sanger sequencing confirmed these mutations and revealed
that E227D is not present in either parent of 101-1, and A44V
is not present in either parent of 103-1; thus, these mutations
arose de novo (Figure 4). Because subject 102-1 is adopted,
we have no parental DNA, but her biological parents are
documented to be unaffected by any skin disease. Neither
E227D nor A44V was found in B2500 control exomes or in
public databases of human genetic variation. E227 is highly
conserved in both orthologous and paralogous genes; A44 is
highly conserved in orthologs (Figure 5, Supplementary Figure
S6 online). GJA1 encodes connexin 43 (Cx43), a widely
expressed gap junction protein.
The GJA1 E227D mutation in subjects 101-1 and 102-1
is at the intracellular boundary of the Cx43 fourth transmem-
brane domain, and it is within the region reported to be
necessary for Cx43 phosphorylation and interaction with
partner protein CIP150 (amino acids 227–242); Cx43
mutant protein lacking this region fails to localize to the
membrane (Akiyama et al., 2005). The observation of two
identical, independent E227D mutations in unrelated EKVP
subjects suggests a critical role for this site in the epidermal
function of Cx43.
SC
G
Figure 1. Clinical and histologic features of erythrokeratodermia variabilis et progressiva (EKVP) due to gap junction protein alpha 1 (GJA1) mutation. (a) The
knee of 101-1 was normal at birth, but it became thickened and scaly when he began to crawl: shown at age 30 months. (b) The knee of 6-year-old 102-1 shows
progression to corrugated, thickened, scaly skin, which has extended beyond sites of friction. (c) The knee of 30-year-old 103-1 shows marked hyperkeratosis with
peeling scale; a patch of figurate erythema is present inferiorly. (d) Histology of affected leg skin of 102-1 shows a compact, thickened stratum corneum (SC) with
retained nuclei (arrow), papillomatosis, a thickened granular layer (G), and a perivascular lymphocytic infiltrate (asterisk).
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The A44V mutation in subject 103-1 is at the extracellular
boundary of the first transmembrane domain. In contrast to
most other paralogs, which have valine at this position and
alanine at a position three residues N-terminal, in Cx43 these
residues are exchanged, with valine at aa41 and alanine at
aa44. In Cx26, an A40V mutation causes keratitis–ichthyosis–
deafness syndrome (Montgomery et al., 2004), despite valine
being wild-type at this site in Cx43 (Figure 5). These data
suggest that these valine–alanine configurations are required
for normal function across paralogs, including the role of Cx43
in the skin.
To examine the consequence of these mutations, we
immunostained tissue sections from wild-type skin and
affected skin of individuals 102-1 and 103-1 with an antibody
to Cx43. In contrast to normal skin, in which Cx43 primarily
localizes to intercellular junctions with faint, uniform cyto-
plasmic staining, both E227D (102-1) and A44V (103-1)
mutants do not localize to the membrane, demonstrating
Figure 2. Prominent white nails and progressive keratoderma in erythrokeratodermia variabilis et progressiva (EKVP) due to gap junction protein alpha 1 (GJA1)
mutation. All subjects show prominent porcelain-white proximal nails without dystrophy. Honeycombed thick hyperkeratosis is present on the palms, and similar
thick hyperkeratosis is present on the feet. Keratoderma is progressive with 30-month-old 101-1 (a), showing less hyperkeratosis than 6-year-old 102-1 (b) or 30-
year-old 103-1 (c). Subject 103-1 is on a systemic retinoid, accounting for peeling seen at lateral aspects of hand and foot and less exuberant hyperkeratosis.
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Figure 3. Figurate erythema and darkening of the skin in erythrokeratodermia variabilis et progressiva (EKVP) owing to gap junction protein alpha 1 (GJA1)
mutation. All subjects report figurate erythema and have experienced progressive skin darkening. (a) In subject 101-1, figurate erythema is present on the back,
flank, arm, and upper thigh. (b) Subject 102-1 shows thick, corrugated keratoderma with darkening prominent on the neck, forearm, axilla, and abdomen. There is
a patch of erythema on the wrist. (c) In subject 103-1, figurate erythema is present on the upper and lower back. Notably, subject 103-1 reports that figurate
erythema became more frequent and prominent at the age of 10 years, but it was present throughout childhood. Treatment with acitretin has reduced scaling, but
hyperpigmentation is prominent on the flanks, shoulders, and neck. In all cases, erythema is induced by stress and warm conditions, and it can be accompanied by
a stinging or burning sensation.
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Figure 4. Gap junction protein alpha 1 (GJA1) mutations in erythrokeratodermia variabilis et progressiva (EKVP) kindreds. (a) Affected and unaffected subjects
are denoted with black and white symbols, respectively; adoption is shown with a dashed line. GJA1 alleles determined by sequencing of genomic DNA are
denoted as ‘þ ’ (wild-type) or by the amino acid substitution in red (mutant). To the right of each pedigree, Sanger sequence traces at GJA1 mutation sites are
shown for each subject and parents from whom DNA was available (mutant bases indicated with *). Amino acid sequences are shown at the top of each trace
(mutant residues in red). Mutations are p.E227D, c.A681T (subjects 101-1 and 102-1), and p.A44V, c.C131T (subject 103-1) (NCBI RefSeq NM_000165).
(b) Schematic model of connexin 43 (Cx43) shows locations of mutations in EKVP subjects reported here (red), and those reported in oculodentodigital dysplasia
(ODDD) (blue), ODDD with palmoplantar hyperkeratosis (purple), and ODDD with Clouston syndrome (green).
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Figure 5. Connexin 43 (Cx43) and paralogs. Transmembrane domains are outlined; conserved residues are shaded gray. Disease-causing Cx43 mutations are
shown above the alignment: erythrokeratodermia variabilis et progressiva (EKVP) reported here (red shade), oculodentodigital dysplasia (ODDD) (blue), ODDD
with palmoplantar hyperkeratosis (purple), and ODDD with Clouston syndrome (green shade); frameshifts (‘fs’), deletions (‘d’), insertions (‘i’). Mutation sites in
paralogs reported to cause skin disease are in orange.
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cytoplasmic localization (Figure 6a-c). To further explore this
Cx43 localization defect, we generated expression constructs
of wild-type, E227D, and A44V mutant Cx43 with a
C-terminal hemagglutinin tag. Constructs were transfected
into HeLa cells and immunostained with an anti-hemaggluti-
nin antibody and an antibody to the cis-Golgi marker GM130.
Although the wild-type protein primarily localized to inter-
cellular junctions, both the E227D and A44V mutants aggre-
gated in a subcellular compartment partly colocalizing with
GM130, suggesting retention in the Golgi (Figure 6d-f).
DISCUSSION
There are 21 connexin-encoding genes identified in the
human genome (Martin et al., 2014). Given the variety of
possible heteromeric connexon configurations, and hetero-
typic gap junction interactions between cells, a mutation in a
single connexin gene has the potential to exert trans-dominant
effects on a number of other connexins expressed in the same
cell type. This may contribute to the spectrum of phenotypes
seen with different mutations within a single connexin-
encoding gene. Mutations in GJB2 (Cx26) can cause
sensorineural hearing loss, palmoplantar keratoderma (with
and without deafness), and keratitis–ichthyosis–deafness syn-
drome. Phenotypes are correlated with mutation conse-
quence, with pure sensorineural deafness resulting from loss
of Cx26 channel function, and skin phenotypes from mechan-
isms including mislocalizaton, endoplasmic reticulum stress
leading to abnormal epidermal differentiation, pathologically
altered hemichannel or gap junction activity, and trans-
dominant effects on localization or function of other connex-
ins (Mes¸e et al., 2007).
Previously described mutations in GJA1 cause oculodento-
digital dysplasia (ODDD) (Paznekas et al., 2003; Laird, 2014),
characterized by distinct facial anomalies including mico-
cephaly, microphthalmia, and a thin nose with hypoplastic
alae nasi, small anteverted nares, and a prominent bridge and
columella. Features with wider phenotypic variability include
other abnormalities of the eyes (microcornea, porous
spongy irises, cataracts, glaucoma, optic atrophy), dentition
(mandibular overgrowth, cleft palate, small or absent teeth,
enamel hypoplasia, multiple caries, early tooth loss), and
digits (syndactyly, short, bent, or flexed fingers and toes).
Brittle nails and hypotrichosis may be present, and there are
frequently neurological symptoms that can include hearing
loss, lower body weakness, spasticity, and incontinence, often
not presenting until adulthood. Mild mental retardation,
cardiac abnormalities, and palmoplantar hyperkeratosis occur
rarely. Our EKVP subjects with GJA1 mutations exhibit none
of these ODDD phenotypes, save mild dental enamel defects
in 102-1 which are not present in 101-1, who shares an
identical mutation, or 103-1 (Figure 2, Supplementary Figure S1
and S3 online), and mild clinodactyly (Figure 2), which can be
found in ODDD but is also present in the general population
(Skvarilova´ and Smahel, 1984).
Over 70 different mutations in GJA1 cause ODDD, and
almost all are heterozygous missense mutations or small
in-frame deletions or insertions occurring before the C-terminal
tail (Laird, 2014). Two kindreds have been reported with
severe ODDD owing to homozygous or compound hetero-
zygous early-termination mutations (Richardson et al., 2006;
Jamsheer et al., 2010), suggesting a dominant-negative
mechanism for the majority of ODDD cases. There are two
frameshift mutations within the Cx43 tail (Y230fsX236 and
C260fsX307) and two missense mutations (L11P and K134E)
that are inconsistently associated with the additional feature of
mild palmoplantar hyperkeratosis (Paznekas et al., 2003; van
Steensel et al., 2005; Kelly et al., 2006; Vreeburg et al., 2007;
Alao et al., 2010), and a single case report describes a subject
with a GJA1 missense mutation (V41L) and a GJB2 mutation
who exhibits features of ODDD and Clouston syndrome with
wt
wt E227D A44V
102–1 103–1
Figure 6. Connexin 43 (Cx43) is mislocalized in erythrokeratodermia variabilis et progressiva (EKVP). (a–c) Cx43 immunolocalization was performed on tissue
sections from wild-type (wt) and affected skin (102-1: E227D, 103-1: A44V), with Cx43 antibody in red and 4’,6-diamidino-2-phenylindole (DAPI) nuclear
counterstain in blue. (a) Wild-type tissue shows primarily intercellular membrane localization of Cx43. (b, c) Affected skin shows primarily cytoplasmic
localization. (d–f) Wild-type (wt) and mutant Cx43 (E227D, A44V) were hemagglutinin-tagged and expressed in HeLa cells. Immunolocalization of Cx43 is red,
cis-Golgi marker GM130 is green, and DAPI nuclear counterstain is blue. (d) Wild-type Cx43 localizes to intercellular junctions and does not colocalize with
GM130. (e, f) The E227D and A44V mutants do not localize to intercellular junctions and accumulate in a subcellular compartment, partly colocalizing with
GM130. Scale bars¼ 20mm in all panels.
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alopecia, nail dystrophy, and well-demarcated, limited hyper-
keratosis of extensor surfaces (Kellermayer et al., 2005).
Neither transient figurate erythema nor generalized erythro-
keratodermia have been reported in ODDD subjects with
GJA1 mutations.
We have shown that previously unreported, dominant, de
novo missense mutations in GJA1 cause a consistent clinical
phenotype of normal skin at birth, which develops hyperpig-
mentation and scale at sites of friction in childhood, with
progression to near-confluent corrugated hyperkeratosis,
palmoplantar keratoderma, and transient figurate erythema.
Although mild palmoplantar hyperkeratosis and limited hyper-
keratosis of extensor surfaces has been found in a small subset
of ODDD patients, the widespread, severe phenotype
described here is distinct. Subjects are without features of
ODDD caused by over 70 other GJA1 mutations, and the
E227D mutation was observed in two out of three unrelated
EKVP subjects, suggesting that EKVP pathology may be
restricted to a small number of GJA1 mutation sites.
Cx43 is the most widely expressed connexin (Laird, 2014).
It is expressed throughout the epidermis, and it is the
predominant connexin in basal proliferating cells (Martin
et al., 2014). Yet, Cx43 itself is not required for epidermal
homeostasis, given that a human homozygous null allele
causes ODDD without skin disease (Richardson et al., 2006),
although Cx43 is upregulated in chronic wounds, and
knockdown of Cx43 speeds wound healing (Becker et al.,
2012; Scott et al., 2012; Martin et al., 2014). In this context,
the induction of initial skin findings in our affected subjects at
sites of friction with subsequent generalization is intriguing.
Our immunostaining shows that GJA1 mutations A44V
and E227D lead to Cx43 mislocalization. In normal skin,
Cx43 localizes to intracellular junctions, whereas in the skin
of our EKVP subjects Cx43 does not localize to the membrane,
and cells transfected with either A44V or E227D mutant
Cx43 demonstrate aggregation of Cx43 in the Golgi. This
mislocalization of Cx43 with an A44V or E227D mutation
stands in stark contrast to the localization observed
with dominant ODDD mutations in Cx43. Of the twenty
ODDD mutations that have been experimentally examined,
the vast majority are expressed at the cell surface, but they
form functionally impaired gap junctions, with a dominant-
negative effect on wild-type Cx43 (Shao et al., 2012). Whether
the observed retention of A44V and E227D mutant Cx43 in
the Golgi contributes to the previously unreported skin-
specific EKVP phenotype we describe, either by trans-
dominant effects on connexins or other proteins as observed
for GJB2 mutations in KID syndrome (Mes¸e et al., 2007), or
by other mechanisms, will require further experimental
investigation.
MATERIALS AND METHODS
Human subjects
The Yale Human Investigation Committee approved the study proto-
col, consistent with the Declaration of Helsinki Principles, and
subjects or their parents provided verbal and written informed
consent, and consented to the publication of images as displayed.
Each subject provided a blood sample and punch biopsies of affected
skin from the upper thigh. De-identified, site-matched normal skin
tissue discarded at the time of skin cancer excisions was obtained for
immunostaining controls. Genomic DNA was isolated from blood
using a standard phenol–chloroform protocol.
Whole-exome sequencing
Bar-coded DNA libraries were prepared and whole-exome capture
was performed (EZ Exome 2.0, Roche, Basel, Switzerland) by the
Yale Center for Genome Analysis. Illumina HiSeq 2000 and 2500
instruments (Illumina, San Diego, CA) were used for sequencing
samples pooled 6 per lane, with 75-bp paired-end reads. The
resulting reads were aligned to the human reference sequence
(hg18 or hg19) with Efficient Large-scale Alignment of Nucleotide
Databases software (ELAND, Illumina) and processed via a SAMtools-
based Perl script to trim sequence to targeted intervals and remove
PCR duplicates. Single-nucleotide variants and deletions and inser-
tions (indels) were identified using the SAMtools software (Li et al.,
2009). Variants were annotated for functional impact using a Perl
script and filtered in Excel to exclude frequent variants present in
dbSNP (Build 140), 1000 Genomes, the NHLBI exome database
(release ESP6500SI-V2), and in 2577 control exomes, and to examine
coding mutations (missense, nonsense, and splice site single-
nucleotide variants and indels) with SAMtools quality scores X50
and coverage X8. Aligned reads were examined with the Broad
Institute Integrative Genomics Viewer to exclude single-nucleotide
variants resulting from alignment error.
Sanger sequencing
Verification of GJA1 mutations and sequencing of parental DNA was
performed via PCR using Kapa 2G Fast polymerase (Kapa Biosystems,
Woburn, MA) and Sanger sequencing. Primers were designed with
ExonPrimer and SNPmasker to specifically amplify GJA1 and not its
pseudogene.
Expression construct generation
A GJA1 complementary DNA clone was obtained (HsCD00332741,
Harvard PlasmID, Brookline, MA) and subcloned into pcDNA3.1( )
Zeo (Invitrogen, Carlsbad, CA). Site-directed mutagenesis to introduce
the A44V or E227D mutations into the wild-type complementary
DNA was performed with QuikChange (Agilent, Santa Clara, CA).
The entire complementary DNA sequence of resulting clones (wild-
type, A44V, and E227D) was sequenced to ensure the absence of
secondary mutation.
Transfections
HeLa cells (CCL-2, ATCC, Manassas, VA) were seeded at a density of
2 104 cells per well on 8-well culture slides (Thermo Fisher
Scientific, Waltham, MA) in DMEMþ 10% fetal bovine serum. Cells
were transfected using Lipofectamine 2000 (Invitrogen) as per
standard protocols and fixed for immunofluorescence studies at
24 hours post transfection.
Immunohistochemistry
5-mm sections from FFPE tissue were deparaffinized using a xylene–
ethanol gradient, rehydrated, and rinsed in phosphate-buffered saline.
Antigen retrieval was performed by immersion in a modified pH 6.0
citrate buffer for 20 minutes in a steamer. Slides were cooled and
rinsed in phosphate-buffered saline. Tissue sections or transfected
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cells were fixed with a 1:1 acetone-methanol mixture for 10 minutes
at  20 1C. Blocking was performed with 10% donkey serum/1% BSA
for 1 hour at room temperature. Slides were incubated for 1 hour with
primary antibody, washed three times with 1X phosphate-buffered
saline, incubated for 1 hour with secondary antibody, and again
washed three times with 1X phosphate-buffered saline before mount-
ing with Mowiol/1% n-propyl gallate (Polysciences, Warrington, PA).
The following primary antibodies were used: 1:100 rabbit anti-Cx43,
1:100 goat anti-hemagglutinin, and 1:70 mouse anti-GM130
(ab11370, ab9134, ab169276; Abcam, Cambridge, England). The
following secondary antibodies were used: 1:10,000 Cy3 donkey
anti-rabbit IgG, 1:10,000 Cy3 donkey anti-goat IgG, and 1:200 Cy2
donkey anti-mouse IgG (711-165-152, 711-165-003, 711-225-150;
Jackson ImmunoResearch, West Grove, PA).
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